Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOTRONIK - A Prospective Multicenter Study to Confirm the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - VII

NCT04175626 is registered in ClinicalTrials.gov with Biotronik, Inc. as lead sponsor.

NCT NCT04175626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04175626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOTRONIK - A Prospective Multicenter Study to Confirm the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - VII
Lead sponsor
Biotronik, Inc.
Phase
Observational
Overall status
Completed
Start date
January 24, 2020
Completion date
January 8, 2026
Enrollment
556 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, angina pectoris, atherosclerosis, coronary, coronary artery disease, ischemic heart disease, myocardial ischemia